← Eichor
Condition: Hereditary Optic Atrophies Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Hereditary Optic Atrophies

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Clinical Trial Readiness for the Dystroglycanopathies
Phase N/A · 1 location(s) · Katherine Mathews · NCT00313677Observational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Patients with Retinal Degener
Phase N/A · 1 location(s) · Ray Therapeutics, Inc. · NCT06375239Phase 1 Study of C.001 in Retinal Degeneration
Phase 1 · 1 location(s) · Cellio Therapeutics Inc · NCT07594236New Non-invasive Modalities for Assessing Retinal Structure and Function
NA · 1 location(s) · Randy Kardon · NCT03475173Development and Evaluation of Functional Visual Field and Navigation Endpoints in Moderate to Profound Inherited Retinal
Phase N/A · 1 location(s) · Ray Therapeutics, Inc. · NCT07502664Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for NAION
Phase 1 · 2 location(s) · The Foundation for Orthopaedics and Regenerative Medicine · NCT05147701A Longitudinal Natural History Study of OPA1-Associated Autosomal-Dominant Optic Atrophy
Phase N/A · 1 location(s) · Ludwig-Maximilians - University of Munich · NCT07729982Modifiable Variables in Parkinsonism (MVP)
Phase N/A · 1 location(s) · Bastyr University · NCT02194816North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)
Phase N/A · 17 location(s) · Columbia University · NCT01694940Gene Therapy Clinical Trial for the Treatment Of Leber's HereDitary Optic Neuropathy
Phase 2/Phase 3 · 1 location(s) · Wuhan Neurophth Biotechnology Limited Company · NCT04912843Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168SGLT2 Inhibitors in Geographic Atrophy
Phase 2 · 1 location(s) · Washington University School of Medicine · NCT07174687Long-Term Development of Muscular Dystrophy Outcome Assessments
Phase N/A · 1 location(s) · Virginia Commonwealth University · NCT05989620The Myelin Disorders Biorepository Project
Phase N/A · 23 location(s) · Children's Hospital of Philadelphia · NCT03047369Development of IPS from Donated Somatic Cells of Patients with Neurological Diseases
Phase N/A · 1 location(s) · Hadassah Medical Organization · NCT00874783Safety of Single and Repeat Dose of PYC-001 Eye Injections in People With Autosomal Dominant Optic Atrophy (Myrtle)
Phase 1/Phase 2 · 3 location(s) · PYC Therapeutics · NCT06970106Efficacy and Safety Study of Bilateral IVT Injection of GS010 at Two Dose Levels in LHON Patients
Phase 2 · 1 location(s) · GenSight Biologics · NCT07303296Monogenic Diabetes Misdiagnosed as Type 1
Phase N/A · 1 location(s) · McGill University Health Centre/Research Institute of the Mc · NCT03988764High Resolution Retinal Imaging
Phase N/A · 1 location(s) · University of Pennsylvania · NCT01866371Metabolomics Analysis According to the Retinal Nerve Fiber Layer in Patients With NOHL Mutations (MétabOCT)
NA · 1 location(s) · Hôpital Necker-Enfants Malades · NCT06682819Wolfram Syndrome and WFS1-related Disorders International Registry and Clinical Study
Phase N/A · 1 location(s) · Washington University School of Medicine · NCT02841553NYSCF Scientific Discovery Biobank
Phase N/A · 1 location(s) · New York Stem Cell Foundation Research Institute · NCT06203106Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)
Phase 3 · 17 location(s) · Laboratoires Thea · NCT06891443Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology
NA · 1 location(s) · Centre Hospitalier Universitaire de Liege · NCT07136844Natural History of Oculo-Pharyngeal Muscular Dystrophy (OPMD) - Israel National OPMD Registry
Phase N/A · 1 location(s) · Sheba Medical Center · NCT07146256A Prospective Observational Study to Assess the Reliability and Validity of the MLSDT
Phase N/A · 1 location(s) · Nanoscope Therapeutics Inc. · NCT06805474Neurodegenerative Diseases Progression Markers (MARKERS-NDD)
Phase N/A · 1 location(s) · Casa di Cura San Raffaele Cassino · NCT06596746Congenital Muscle Disease Study of Patient and Family Reported Medical Information
Phase N/A · 1 location(s) · Cure CMD · NCT01403402Neurologic Stem Cell Treatment Study
NA · 3 location(s) · MD Stem Cells · NCT02795052Inherited Retinal Degenerative Disease Registry
Phase N/A · 1 location(s) · Foundation Fighting Blindness · NCT02435940
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.